Back to search

University of British Columbia

Tissue engineering : an approach to develop tools for bladder cancer treatment

Abstract

dc:description

Bladder cancer (BCa) is the fifth most common cancer in Canada, with high recurrence and progression rates, making it the most expensive cancer to treat. Muscle-invasive BCa is currently managed with radical cystectomy and neoadjuvant chemotherapy. However, one clinical limitation is the inability to predict which patients will benefit from chemotherapy. There are some predictive tumor models to guide individual treatment. Unfortunately, they do not fulfill all requirements. Tissue engineering offers novel strategies for regenerative medicine and cancer research through the development of in vitro models. Adipose-derived stem cells (ASCs) possess the ability to differentiate into multiple lineages and have shown anti-inflammatory, anti-fibrotic, and pro-angiogenic effects, making them a promising alternative cell source for bladder reconstruction. This project proposes to use tissue engineering to develop a 3D patient-derived bladder tumor model for preclinical drug testing and to reconstruct a functional urothelium using ASCs. Decellularized swine bladders were used as scaffolds for UM-UC3 cell growth, successfully creating a 3D cancer model. Treatment with Cisplatin (Cis) and Gemcitabine (Gem) showed decreased cell proliferation. Tumor samples from BCa patients were also used to recreate the model and test their chemotherapy response. The clinical response was compared with the BCa model in 6 patients, finding a positive correlation in treatment response in 5 out of 6 patients, resulting in an 83.3% reliability in the BCa model. ASCs were successfully isolated and characterized. Transdifferentiation was evaluated using a co-culture system with SV-HUC cells. Further analysis of urothelial-like cells (ULCs) showed a loss of stem cell markers and increased urothelial markers. For the functional assay, ULCs were cultured in in conditions resembling the native bladder. After 14 days in culture ULCs formed layers and expressed uroplakin markers, indicating full differentiation. This 3D cancer model allows to generate patient-specific tumor models, enabling the simultaneous testing of multiple anti-cancer drugs ex vivo. Additionally, the successful transdifferentiation of ASCs into functional urothelial cells opens new avenues for innovative bladder reconstruction strategies. Overall, this project will develop tools to improve the actual treatment for BCa, which could be translated into the improvement of the quality of life of patients.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Interdisciplinary Oncology
Grantor dc:publisher
University of British Columbia
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Monjaras Avila, Cesar Ulises
Contributors dc:contributor
  • So, Alan
  • Chavez-Munoz, Claudia

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/90551

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Monjaras Avila, Cesar Ulises. Tissue engineering : an approach to develop tools for bladder cancer treatment. doctoral thesis, University of British Columbia, 2025. http://hdl.handle.net/2429/90551